Pharmafile Logo
Pharmafocus logo
Advanced Search

drug safety

Showing 15 posts of 32 posts found.

trump-fda

Trump’s FDA: Is the US regulator being steered by the President?

September 9, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Trump, US, drug safety, pharma

FDA activity has fallen under Donald Trump, with the number of warning letters issued by the regulator dropping by a …

Feature

PV futures: Pharmacovigilance as a solution to the challenges of tomorrow

March 11, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug safety, feature, pharma, pharmacovigilance

Louis Goss asks what the future might hold for the safety of pharmaceuticals and looks into why crucial pharmacovigilance practices …

Feature
drug_safety

Drug safety: UK and EU post-Brexit

September 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, Europe, MHRA, UK, brexit, drug safety, pharmacovigilance

What does Brexit mean for drug safety in Europe and the United Kingdom? Louis Goss looks into Britain’s exit from …

Feature
pharmafocus_oct_2018

The September 2018 issue of Pharmafocus is available to read online now!

September 3, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, AstraZeneca, Cancer, Iraw, J&J, JJ, Pfizer, Roche, UK, brexit, drug safety, pharma, pharmacovigilance

The new September edition of Pharmafocus is now live and available to read online. We’re entering the final stretch as …

News

CCP fire provincial official and investigate drug regulator in response to Changsheng vaccine scandal

August 17, 2018
Medical Communications China, Vaccine, changsheng, drug safety, regulation

The Chinese government has fired a senior provincial official and is probing a former senior drug regulator in response to …

News
shutterstock_79370437

Drug safety: EudraVigilance and an evolving system

March 12, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug safety, pharma, pharmacovigilance

The importance of drug safety is back in the news due to sodium valproate and Ben Hargreaves examines how the …

Feature
pharmafocus_march_2018_cover

Pharmafocus March 2018 is available to read online now!

February 28, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, brexit, drug safety, pharma, real world data

Though never truly out of vogue, the drug pricing debate has flared up again with the White House’s release of …

News
shutterstock_79370437

Asking the right questions: Measuring the impact of pharmacovigilance

October 16, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug safety, pharma, pharmacovigilance

Are our pharmacovigilance measures as effective as we think? And why is it important to answer that question, especially now? …

Feature
EMA HQ

EMA concludes HPV vaccines do not cause CRPS or POTS

November 9, 2015
Sales and Marketing EMA, HPV, HPV vaccine, PRAC, complex regional pain syndrome, drug safety, postural orthostatic tachycardia syndrome

The European Medicines Agency says there is no evidence from a detailed scientific review of reports linking complex regional pain …

News

AstraZeneca halts lung cancer trials amidst safety concerns

October 13, 2015
Manufacturing and Production AZD9291, AstraZeneca, MEDI4736, NSCLC, drug safety, durvalumab, interstitial lung disease, lung cancer, non-small cell lung cancer

AstraZeneca is stopping two trials of a combination of two of its pipeline cancer treatments, after reports that the pairing …

News
Zoloft

Pfizer and GSK in antidepressant safety probes

September 22, 2015
Manufacturing and Production GSK, Paxil, Pfizer, Zoloft, antidepressants, drug safety, paroxetine, sertraline

Two top-selling antidepressants have had their safety records challenges, after the FDA asked Pfizer to change the labelling of its …

News
FDA sign

FDA issues gliptin joint pain warning

September 1, 2015
Manufacturing and Production DPP-4 inhibitors, ESC, FDA, TECOS, adverse effects, drug safety, gliptins, safety alert, safety warning

The FDA has issued a safety alert, warning of joint pain caused by the gliptins, a common class of drugs …

News

Spiriva mist inhaler safety concerns raised

June 16, 2011
Sales and Marketing Boehringer Ingelheim, Spiriva, drug safety

A mist inhaler used to deliver Spiriva to patients with chronic obstructive pulmonary disease (COPD) may be linked to an …

News

French pharma firm denies drug risk cover up

May 10, 2011
Sales and Marketing Mediator, Servier, drug safety

France’s second biggest pharma firm Servier has denied allegations it concealed risks associated with its diabetes drug Mediator (benfluorex). Research …

News

Servier’s Mediator provokes French drug safety controversy

January 12, 2011
Sales and Marketing AFSSAPS, France, Mediator, Servier, benfluorex, drug safety

Serious questions are being asked about drug safety monitoring in France in connection with Servier’s Mediator (benfluorex) which was withdrawn …

News

Latest content

BactiVac funds development of bacterial vaccines to prevent infections against antimicrobial resistance

September 28, 2023

Avalyn Pharma raises $175m in Series C financing for inhalation therapies

September 28, 2023

NMD Pharma begins phase 2 trial for spinal muscular atrophy treatment

September 27, 2023

Alfasigma to acquire Intercept Pharmaceuticals for $19 per share

September 27, 2023

Regeneron and Sanofi’s sBLA for Dupixent accepted by FDA for priority review

September 26, 2023